Skip to content

A prospective study for assessment of cardiovascular risk in polycystic ovarian syndrome

A prospective study for assessment of cardiovascular risk in polycystic ovarian syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000092
Enrollment
350
Registered
2011-01-28
Start date
2010-10-28
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Ewha Womans University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. age: 25-34 years old 2. oligomenorrhea: menstrual cycle>35days, less than 10 menstrual cycle/year 3. Hyperandrogenenmia: total T >65ng/dL, calculated free T >0.86ng/dL 4. normal prolactin level 5. no drugs users( hormone drug, insulin sensitizing drug, weight control drug, antihypertensive drugs) within three months of testing 6. other standards set by steering committee

Exclusion criteria

Exclusion criteria: 1. Hyperprolactinemia 2. Congenital adrenal hyperplasia 3. Cushinng sybdrome 4. Other endocrine disorder which caused hyperandrogenism 5. androgen-secreting tumors 6. drugs users( hormone drug, insulin sensitizing drug, weight control drug, antihypertensive drugs) within three months of testing 7. other standards set by steering committee

Design outcomes

Primary

MeasureTime frame
hypertension;Dyslipidemia;obesity;intermediate marker of CV disease;metabolic syndrome

Secondary

MeasureTime frame
impaired glucose tolerance;insulin resistance

Countries

Korea, Republic of

Contacts

Public ContactHwanji Kim

Ewha Womans University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026